Jinhe Biotechnology Co Ltd (002688)

Currency in CNY
7.60
+0.26(+3.54%)
Closed·
002688 Scorecard
Full Analysis
Management has been aggressively buying back shares
002688 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.307.68
52 wk Range
3.408.69
Key Statistics
Bid/Ask
7.61 / 7.61
Prev. Close
7.34
Open
7.32
Day's Range
7.3-7.68
52 wk Range
3.4-8.69
Volume
64.52M
Average Volume (3m)
57.76M
1-Year Change
95.06%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002688 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Jinhe Biotechnology Co Ltd Company Profile

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD. was founded in 1990 and is based in Dalian, China.

Employees
2476
Market
China

Compare 002688 to Peers and Sector

Metrics to compare
002688
Peers
Sector
Relationship
P/E Ratio
37.5x30.5x−0.5x
PEG Ratio
0.54−0.020.00
Price/Book
2.4x2.2x2.6x
Price / LTM Sales
2.0x4.0x3.3x
Upside (Analyst Target)
-4.8%43.5%
Fair Value Upside
Unlock5.0%6.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.19%
Dividend Yield
1.36%
Industry Median 1.51%
Annualised payout
0.10
Paid annually
5-Years Growth
-16.74%
Growth Streak

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
0.11 / --
Revenue / Forecast
765.11M / --
EPS Revisions
Last 90 days

002688 Income Statement

FAQ

What Stock Exchange Does Jinhe Biotechnology A Trade On?

Jinhe Biotechnology A is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Jinhe Biotechnology A?

The stock symbol for Jinhe Biotechnology A is "002688."

What Is the Jinhe Biotechnology A Market Cap?

As of today, Jinhe Biotechnology A market cap is 5.72B.

What Is Jinhe Biotechnology A's Earnings Per Share (TTM)?

The Jinhe Biotechnology A EPS (TTM) is 0.19.

When Is the Next Jinhe Biotechnology A Earnings Date?

Jinhe Biotechnology A will release its next earnings report on 02 Nov 2025.

From a Technical Analysis Perspective, Is 002688 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Jinhe Biotechnology A Stock Split?

Jinhe Biotechnology A has split 2 times.

How Many Employees Does Jinhe Biotechnology A Have?

Jinhe Biotechnology A has 2476 employees.

What is the current trading status of Jinhe Biotechnology A (002688)?

As of 05 Aug 2025, Jinhe Biotechnology A (002688) is trading at a price of 7.60, with a previous close of 7.34. The stock has fluctuated within a day range of 7.30 to 7.68, while its 52-week range spans from 3.40 to 8.69.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.